Tris Pharma Announces Acceptance Of New Publication Highlighting Promise Of Dual NOP-MOP (Dual-NMR) Agonists For The Treatment Of Moderate-To-Severe Pain January 8, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110573160/Tris-Pharma-Announces-Acceptance-Of-New-Publication-Highlighting-Promise-Of-Dual-NOP-MOP-Dual-NMR-Agonists-For-The-Treatment-Of-Moderate-To-Severe-Pain
